PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PDAC - PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radiation and immunotherapy join forces against deadly pancreatic cancer
Disease control Not yet recruitingThis study is testing whether adding targeted radiation and an immunotherapy drug to standard chemotherapy helps people with advanced pancreatic cancer live longer. It will involve about 200 adults who haven't had prior treatment for their metastatic cancer. The goal is to see if…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Lab-Grown tumors could predict best cancer drugs
Knowledge-focused Not yet recruitingThis study aims to test whether growing tiny tumor models from a patient's own cancer cells in a lab can help predict which standard cancer drugs will work best for them. Researchers will enroll 188 adults with colorectal or pancreatic cancer who are scheduled for surgery or biop…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: Luxembourg Institute of Health • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC